Literature DB >> 6389544

Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats.

T Kadowaki, M Kasuga, Y Akanuma, O Ezaki, F Takaku.   

Abstract

It has been documented that streptozotocin-induced diabetes in rats is associated with diminished effects of insulin despite increased insulin binding to its receptor. This paradox led us to examine whether any alterations of insulin receptor-kinase activities occur in this type of insulin resistance. Insulin binding capacity/mg of protein of solubilized, wheat germ agglutinin-purified preparations from livers was increased by 1.8-fold in the streptozotocin (65 mg/kg) diabetic rats. This increase was associated with a parallel increase in receptor protein as measured by an immunoblotting method using anti-insulin receptor antibody. Moreover, no apparent change was observed in the stoichiometry of alpha and beta subunits of the insulin receptor between diabetic and control rats. Insulin-stimulated (10(-7) M) phosphorylation of the beta subunit of the insulin receptor was decreased by 40% in diabetic rats when equal quantities of insulin binding capacity were compared. Phosphorylation of an exogenously added synthetic peptide (similar in sequence to the tyrosine phosphorylation site in pp60src) by the insulin receptor-kinase was also decreased by 25% in diabetic rats. These abnormalities were partially restored by in vivo insulin treatment. These data suggest that diminished insulin receptor autophosphorylation and kinase activity could provide a possible mechanism for the "post-binding insulin resistance" in diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389544

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  High blood glucose does not adversely affect outcome in moderately brain-injured rodents.

Authors:  Julia Hill; Jing Zhao; Pramod K Dash
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

2.  Insulin resistance of glucose metabolism in isolated brown adipocytes of lactating rats. Evidence for a post-receptor defect in insulin action.

Authors:  A F Burnol; S Ebner; J Kandé; J Girard
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

Review 3.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

Review 4.  The insulin receptor and the molecular mechanism of insulin action.

Authors:  C R Kahn; M F White
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

Review 5.  The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance.

Authors:  H U Häring
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

Review 6.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

7.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

Authors:  F Giorgino; A Almahfouz; L J Goodyear; R J Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 8.  Insulin receptors: structure and function.

Authors:  E Van Obberghen; S Gammeltoft
Journal:  Experientia       Date:  1986-07-15

9.  Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin.

Authors:  Siegfried Hoyer; Heinrich Lannert
Journal:  J Neural Transm (Vienna)       Date:  2008-08-05       Impact factor: 3.575

10.  Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.

Authors:  M J Saad; E Araki; M Miralpeix; P L Rothenberg; M F White; C R Kahn
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.